124 related articles for article (PubMed ID: 27864052)
1. Tumor tissue slice cultures as a platform for analyzing tissue-penetration and biological activities of nanoparticles.
Merz L; Höbel S; Kallendrusch S; Ewe A; Bechmann I; Franke H; Merz F; Aigner A
Eur J Pharm Biopharm; 2017 Mar; 112():45-50. PubMed ID: 27864052
[TBL] [Abstract][Full Text] [Related]
2. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
[TBL] [Abstract][Full Text] [Related]
3. Analysis of polymeric nanoparticle properties for siRNA/DNA delivery in a tumor xenograft tissue slice air-liquid interface model.
Karimov M; Scherer M; Franke H; Ewe A; Aigner A
Biotechnol J; 2023 Apr; 18(4):e2200415. PubMed ID: 36541426
[TBL] [Abstract][Full Text] [Related]
4. Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo.
Ewe A; Panchal O; Pinnapireddy SR; Bakowsky U; Przybylski S; Temme A; Aigner A
Nanomedicine; 2017 Jan; 13(1):209-218. PubMed ID: 27553077
[TBL] [Abstract][Full Text] [Related]
5. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A
J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
[TBL] [Abstract][Full Text] [Related]
7. Spray-Dried Nanoparticle-in-Microparticle Delivery Systems (NiMDS) for Gene Delivery, Comprising Polyethylenimine (PEI)-Based Nanoparticles in a Poly(Vinyl Alcohol) Matrix.
Schulze J; Kuhn S; Hendrikx S; Schulz-Siegmund M; Polte T; Aigner A
Small; 2018 Mar; 14(12):e1701810. PubMed ID: 29430833
[TBL] [Abstract][Full Text] [Related]
8. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
10. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
11. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles.
Swami A; Goyal R; Tripathi SK; Singh N; Katiyar N; Mishra AK; Gupta KC
Int J Pharm; 2009 Jun; 374(1-2):125-38. PubMed ID: 19446769
[TBL] [Abstract][Full Text] [Related]
12. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
13. Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery.
Ewe A; Schaper A; Barnert S; Schubert R; Temme A; Bakowsky U; Aigner A
Acta Biomater; 2014 Jun; 10(6):2663-73. PubMed ID: 24590163
[TBL] [Abstract][Full Text] [Related]
14. Unique Surface Modification of Silica Nanoparticles with Polyethylenimine (PEI) for siRNA Delivery Using Cerium Cation Coordination Chemistry.
Kapilov-Buchman Y; Lellouche E; Michaeli S; Lellouche JP
Bioconjug Chem; 2015 May; 26(5):880-9. PubMed ID: 25830668
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of Fe
Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
[TBL] [Abstract][Full Text] [Related]
16. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
17. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
19. Acute in vivo toxicity mitigation of PEI-coated maghemite nanoparticles using controlled oxidation and surface modifications toward siRNA delivery.
Israel LL; Lellouche E; Ostrovsky S; Yarmiayev V; Bechor M; Michaeli S; Lellouche JP
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15240-55. PubMed ID: 26120905
[TBL] [Abstract][Full Text] [Related]
20. Polyethylenimine-based amphiphilic core-shell nanoparticles: study of gene delivery and intracellular trafficking.
Siu YS; Li L; Leung MF; Lee KL; Li P
Biointerphases; 2012 Dec; 7(1-4):16. PubMed ID: 22589059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
